IHA Director Professor Linda Partridge is one of the organisers of the new Wellcome Trust Conference on Healthy Ageing being held 18-20 May 2015.
Ageing can lead to declining health and function, and it is the major risk factor for cancer, neurodegenerative and cardiovascular disease. This new Wellcome Trust conference will focus on recent discoveries and current challenges in ageing research, with a focus on translating basic research insights into health improvement for older people. We aim to explore the mechanisms of ageing in cells, tissues and organisms in order to identify interventions that can ameliorate its negative effects. The meeting will also emphasise the connection between discoveries made in model organisms and mechanisms leading to healthy ageing in humans.
The meeting is aimed at scientists, clinicians and drug developers involved in research into ageing and other relevant fields. We welcome the submission of abstracts from all areas relevant to the main themes of the meeting. Several oral presentations will be chosen from the abstracts submitted.
Topics will include: Human ageing Stem cells and cellular senescence, Physiology of homeostasis, Nutrition and metabolism, Genome stability, Epigenetics, Systems biology, Drug developmen. More...
Published: Mar 9, 2015 3:44:49 PM
Congratulations to Dr Nazif Alic whose paper has been published in the Royal Society's flagship biological research journal Proceedings B.
Published: Dec 18, 2014 5:19:24 PM
Published: Dec 4, 2014 11:04:44 AM
The Institute of Healthy Ageing (Director: Prof Dame Linda Partridge,
DBE, FRS, FRSE, FMedSci) is an interdisciplinary centre of excellence
for research on the biology of ageing and ageing-related diseases. The
biological process of ageing contributes to increased risk of a wide
range of diseases, from neurodegenerative diseases (e.g. Alzheimer's and
Parkinson's disease) and cancer to cardiovascular disease (causing
heart attack and stroke) and age-related macular degeneration (causing
blindness in the elderly).
Our primary purpose is to bring together researchers working on the basic biology of ageing (biogerontology) with those working to understand the causes of ageing-related disease. By merging the two, we aim to develop a new translational biogerontology using the ageing process as a point of intervention to protect against the diseases of old age. Our goal is to improve the health and quality of life for older people.
The work of the Institute of Healthy Ageing is pursuing these ends by:
- Conducting world class research on the biology of ageing and ageing-related disease
- Increasing capacity in research on the biology of ageing by training new researchers and nurturing the work of younger principal investigators
- Teaching about the biology of ageing at undergraduate and postgraduate levels
problem of ageing is not just an issue of biology, but also of social
science, economics and the built environment. A secondary aim of the
Institute is to nurture broader collaborations across UCL between
researchers working on different aspects of ageing.
We aim, through our combined activities, to transform healthcare technology and the social conditions of the elderly to create a future society in which the lives of older people are healthy, meaningful and happy.
Our facilities are shared with the associated Bähler Lab, headed by Professor Jürg Bähler.
Page last modified on 03 jul 13 14:38